๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

[131I]-META-IODOBENZYLGUANIDINE IN TREATMENT OF MALIGNANT PHAEOCHROMOCYTOMAS

โœ Scribed by Vetter, H.; Fischer, M.; Muller-Rensing, R.; Vetter, W.; Winterberg, B.


Book ID
123340088
Publisher
The Lancet
Year
1983
Tongue
English
Weight
257 KB
Volume
322
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Modification by nifedipine of131I-meta-i
โœ Glen M. Blake; Valerie J. Lewington; John S. Fleming; Maureen A. Zivanovic; Dunc ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 354 KB

Following a case report that oral nifedipine can suppress the secretion of noradrenaline by phaeochromocytoma, we examined the effect of nifedipine on the tumour kinetics of tracer 131I-meta-iodobenzylguanidine (131I-mIBG) in five patients referred for mIBG radionuclide therapy for disseminated mali

Treatment of advanced neuroblastoma with
โœ Alberto Garaventa; Dr. Bruno De Bernardi; Edoardo Lanino; Paolo Guerra; Mario Be ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 635 KB

31 children with advanced pretreated neuroblastoma were treated with 131-1 meta-Iodobenzylguanidine (131-MIBG). Thirteen children had been resistant to first-line therapy, three had suffered a local relapse, and fourteen had suffered a disseminated relapse without overt bone marrow infiltration. On

Toxicity from treatment of neuroblastoma
โœ James C. Sisson; Raymond J. Hutchinson; James E. Carey; Brahm Shapiro; Jon W. Jo ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 415 KB

Toxic effects from 131I-meta-iodobenzylguanidine (131I-MIBG) treatments of neuroblastoma in six patients were recorded. The toxicity was largely confined to the hematologic system where circulating leukocytes and platelets regularly declined after each dose of 131I-MIBG; the values reached nadirs be

No-carrier-added synthesis of meta-[131I
โœ Ganesan Vaidyanathan; Michael R. Zalutsky ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 806 KB

No-carrier-added meta-[131I]iodobenzylguanidine ([131I]MIBG) was prepared starting with two different metallated precursors. Attempted preparation of 3-(tri-n-butylstannyl)benzylguanidine was not successful. An alternate two-step strategy using 3-(tri-n-butylstannyl)benzylamine could be used to prep